KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inovio Pharmaceuticals (INO) Long-Term Debt Repayments (2024)

Historic Long-Term Debt Repayments for Inovio Pharmaceuticals (INO) over the last 1 years, with Q1 2024 value amounting to $16.4 million.

  • Inovio Pharmaceuticals' Long-Term Debt Repayments changed N/A to $16.4 million in Q1 2024 from the same period last year, while for Dec 2024 it was $16.4 million, marking a year-over-year change of. This contributed to the annual value of $16.4 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2024, Inovio Pharmaceuticals' Long-Term Debt Repayments is $16.4 million.
  • Over the past 5 years, Inovio Pharmaceuticals' Long-Term Debt Repayments peaked at $16.4 million during Q1 2024, and registered a low of $16.4 million during Q1 2024.